13.54 USD
↘ 0.08 (0.59%)AT CLOSE (11:59 AM EDT)
InMode Ltd. Ordinary Shares
INMDNASDAQ • USD
13.51
↘ 0.03 (0.19%)
POST MARKET (AS OF 07:41 PM EDT)
Post Market
AS OF 07:41 PM EDT
13.51
↘ 0.03 (0.19%)
Market: CLOSED
Open?$13.64
High?$13.69
Low?$13.46
Prev. Close?$13.62
Volume?497.3K
Avg. Volume?891.9K
VWAP?$13.57
Rel. Volume?0.56x
Bid / Ask
Bid?$13.35 × 300
Ask?$14.00 × 100
Spread?$0.65
Midpoint?$13.68
Valuation & Ratios
Market Cap?857.9M
Shares Out?63.4M
Float?55.8M
Float %?88.0%
P/E Ratio?14.51
P/B Ratio?2.92
EPS?$0.93
Dividend?0.00%
Ex-Dividend?N/A
InMode Ltd. Ordinary Shares (INMD) is currently trading at $13.54. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (20.1%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, INMD appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?20.38Safe
Confidence?38%Very Low
Short InterestElevated
Short % of Float?5.51%Elevated
Short Interest?3.1M
Days to Cover?3.1
Free Float55.8M
Avg Daily Volume1.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.22Strong
Cash Ratio?1.77Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?14.5CHEAP▾
Peers100
S&P82
P/B?2.92CHEAP▾
Peers100
S&P57
P/S?5.50FAIR▾
Peers100
S&P25
P/FCF?13.9CHEAP▾
Peers100
S&P78
EV/EBITDA?13.6FAIR▾
Peers100
S&P59
EV/Sales?5.08FAIR▾
Peers100
S&P35
Returns & Efficiency
ROE?20.1%STRONG▾
Peers50
S&P66
ROA?17.5%STRONG▾
Peers50
S&P92
Cash Flow & Enterprise
FCF?$61.8M
Enterprise Value?$793.0M
Fundamentals ratios updated end of day